Why the Difference Was Smaller Than Researchers Expected

According to a study published in the Journal of Asthma and Allergy by researchers C.-T. Hung, C.-Y. An, C.-W. Suk, T.-W. Lee, and S.-H. Hung, adult patients with asthma and type 2 diabetes who use tirzepatide experience a similar risk of asthma exacerbations over a 12-month period compared to those using semaglutide. The retrospective cohort … Read more

Are GLP-1 Drugs Psychiatrically Safe? One Question Remains

Millions of patients taking glucagon-like peptide-1 receptor agonists (GLP-1RAs) for type 2 diabetes and obesity face renewed clarity regarding psychiatric safety, according to a systematic review published in the journal Cureus by Quadir et al. Researchers evaluating 11 primary studies representing over 4.9 million patients found no consistent class-wide increase in neuropsychiatric risks such as … Read more

Dual-Drug Microneedle Patch for Inflammation and Fat Browning

According to researchers at Wuhan University, more than 3 billion people worldwide currently suffer from obesity, a figure forecasted to exceed 4 billion by 2035. To combat weight rebound and inflammation-suppressed fat browning linked to single-agent therapies, scientists developed an adipose-targeted composite microneedle patch named LRSG-SG@MN, which co-delivers semaglutide and rosiglitazone to modulate immune response … Read more

6 Science-Backed Benefits of Drinking Black Coffee Daily, According to an Oncologist

Black coffee offers significant health benefits when consumed without excess sugar or high-calorie additives, according to Dr. Vartika Vishwani. In a recent analysis of daily habits shared by the oncologist, regular black coffee consumption links directly to a lower risk of premature death, chronic illnesses, and specific organ damage. While caffeine is not a miracle … Read more

3 Habits to Delay Dementia Risk in Middle Age

According to a study published in Neurology Open Access, avoiding smoking, managing high blood pressure, and preventing Type 2 diabetes can delay the onset of dementia by nearly 13 years. Researchers monitored more than 12,400 dementia-free participants starting at age 55 for an average of 26 years, tracking how cardiovascular risk factors influence cognitive decline … Read more

Hidden Metabolic Risks in Non-Obese HIV Patients: New Research

People living with well-controlled HIV face an elevated risk of developing type 2 diabetes due to increased scarring in their fat tissues, according to a University of California – San Francisco study published June 30 in JCI Insight. Fat Fibrosis and Insulin Resistance in HIV Researchers at UCSF investigated why patients with suppressed HIV maintain … Read more

Can Fibre Lower HbA1c by 1%? What Experts Say

Managing diabetes with 10 to 12 grams of daily soluble fiber can significantly reduce post-meal sugar spikes and lower HbA1c levels, according to nutritionist Dr. Rebecca Pinto, though endocrinologist Dr. Himika Chawla emphasizes that fiber works best alongside balanced meals, regular exercise, and medical treatment rather than serving as a standalone cure. Can Soluble Fibre … Read more

PPAR Receptors: A New Therapeutic Target for Rare Liver Disease

Primary biliary cholangitis is a rare autoimmune disease affecting small bile ducts within the liver, causing bile to build up and trigger progressive liver damage that can eventually lead to cirrhosis, according to recent medical studies. Because the immune system attacks these vital ducts, roughly 40% of patients fail to respond adequately or cannot tolerate … Read more

Is Coffee Good for Your Heart? The Surprising Truth About Caffeine

Caffeine Consumption and Heart Health: What the Latest Science Says Moderate caffeine intake—defined as up to 400 mg daily, or roughly three to five 8-ounce cups of black coffee—is generally safe for most adults and may be linked to a lower risk of cardiovascular conditions like stroke and heart failure, according to a recent scientific … Read more

GLP-1 Receptor Activation Linked to Reduced Depression, Bipolar Disorder Risk

Genetic Insights into GLP-1R and Mental Health Genetic evidence suggests that lifelong activation of the glucagon-like peptide-1 receptor (GLP-1R) may reduce risks of major depressive disorder (MDD) and bipolar disorder (BD), according to a study published in Translational Psychiatry. Researchers used Mendelian randomization (MR) to analyze data from genome-wide association studies (GWASs), linking genetic variants … Read more